| Articles Reviewed |
| 1: | Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 2: | Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 |
| 3: | Ying H Shen et al. Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling. A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cel. 2006 |
| 4: | Francis Edwin et al. The tumor suppressor PTEN is necessary for human Sprouty 2-mediated inhibition of cell proliferation. 2006 |
| 5: | Jeffrey R Skaar et al. Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development. 2005 |
| 6: | Xiu-Mei Ma et al. Relation of overexpression of S phase kinase-associated protein 2 with reduced expression of p27 and PTEN in human gastric carcinoma. 2005 |
| 7: | Lindsey D Mayo et al. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified. 2005 |
| 8: | Christine Farrar et al. Activation of the PI3K/Akt signal transduction pathway and increased levels of insulin receptor in protein repair-deficient mice. 2005 |
| 9: | Kip M Connor et al. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. 2005 |
| 10: | Lenin Mahimainathan et al. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. 2004 |
| 11: | Weidong Wu et al. Zinc-induced PTEN protein degradation through the proteasome pathway in human airway epithelial cells. 2003 |
| 12: | Ole J Halvorsen et al. Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. 2003 |
| 13: | Daniel J Freeman et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. 2003 |
| 14: | Zhenbao Yu et al. PTEN associates with the vault particles in HeLa cells. 2002 |
| 15: | Diana Birle et al. Negative feedback regulation of the tumor suppressor PTEN by phosphoinositide-induced serine phosphorylation. 2002 |
| 16: | Hong Wang et al. DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. 2002 |
| 17: | Giles O Hellawell et al. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. 2002 |
| 18: | Guang Yang et al. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. 2002 |
| 19: | Wei Liu et al. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways. 2002 |
| 20: | H Huang et al. PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. 2001 |
| 21: | R A Campbell et al. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. 2001 |